← back to search

Mark Sausen

Human Genome Sciences (United States) · US
Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Cancer Immunotherapy and Biomarkers, and Colorectal Cancer Treatments and Studies.
h-index
31
citations
13,564
works
255
NIH funding
primary concept
email

Recent publications

ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results
Nature Medicine 2023cited by 137position: middledoi
Homologous Recombination Deficiency: Concepts, Definitions, and Assays
The Oncologist 2022cited by 223position: middledoi
788O Association of pre-treatment ctDNA with disease recurrence and clinical and translational factors in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy (CheckMate 915)
Annals of Oncology 2022cited by 18position: middledoi
Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study
BMC Cancer 2020cited by 58position: middledoi
Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Clinical Cancer Research 2019cited by 153position: lastdoi
Direct detection of early-stage cancers using circulating tumor DNA
Science Translational Medicine 2017cited by 1,144position: middledoi
The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA
Clinical Cancer Research 2016cited by 177position: middledoi
Whole-Exome Sequencing of Salivary Gland Mucoepidermoid Carcinoma
Clinical Cancer Research 2016cited by 97position: middledoi
Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma
Cancer Prevention Research 2016cited by 96position: middledoi
Genomic and Immunological Tumor Profiling Identifies Targetable Pathways and Extensive CD8+/PDL1+ Immune Infiltration in Inflammatory Breast Cancer Tumors
Molecular Cancer Therapeutics 2016cited by 60position: middledoi
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
Science Translational Medicine 2015cited by 499position: middledoi
The genomic landscape of response to EGFR blockade in colorectal cancer
Nature 2015cited by 492position: middledoi
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
Nature Communications 2015cited by 483position: firstdoi
Personalized genomic analyses for cancer mutation discovery and interpretation
Science Translational Medicine 2015cited by 427position: middledoi
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Science Translational Medicine 2014cited by 5,064position: middledoi
DETECTION OF CIRCULATING TUMOR DNA IN EARLY AND LATE STAGE HUMAN MALIGNANCIES
Neuro-Oncology 2014cited by 446position: middledoi
Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors
Nature Genetics 2014cited by 312position: middledoi
Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade
Journal for ImmunoTherapy of Cancer 2014cited by 214position: middledoi
Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes
Nature Communications 2014cited by 169position: middledoi
Circulating tumor DNA moves further into the spotlight
Genome Medicine 2014cited by 25position: firstdoi
Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing
Science Translational Medicine 2012cited by 634position: middledoi
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
Nature Genetics 2012cited by 414position: firstdoi
Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations in RET and RAS
The Journal of Clinical Endocrinology & Metabolism 2012cited by 253position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Siân Jones · Human Genome Sciences (United States)9 papers (2012–2019)Victor E. Velculescu · Sidney Kimmel Cancer Center9 papers (2012–2019)Luis A. Díaz · Secretaria de Salud9 papers (2012–2019)Nickolas Papadopoulos · Ludwig Cancer Research5 papers (2012–2016)Kenneth W. Kinzler · University of Baltimore5 papers (2012–2016)Bert Vogelstein · Clinical Pharmacology of Miami5 papers (2012–2016)Sonya Parpart-Li · Center for Cancer Research3 papers (2015–2016)Samuel V. Angiuoli · Weill Cornell Medicine3 papers (2014–2019)Rebecca Leary · Novartis (United States)3 papers (2012–2015)Laura D. Wood · Wellcome Sanger Institute3 papers (2014–2016)Nishant Agrawal · Institute of Chartered Financial Analysts of India3 papers (2014–2016)Valsamo Anagnostou · Cornell University3 papers (2015–2023)Derek Murphy · University of Edinburgh3 papers (2015–2019)Manish Shukla · Pennsylvania State University2 papers (2014–2015)Ralph H. Hruban · Occupational Cancer Research Centre2 papers (2014–2015)David R. Riley · University of Liverpool2 papers (2015–2019)Jonathan Baden · Bristol-Myers Squibb (United States)2 papers (2022–2022)Julie R. Brahmer · Bloomberg (United States)2 papers (2016–2023)Bjarne R. Bartlett · State University of New York2 papers (2016–2019)Justin A. Bishop · Southwestern Medical Center2 papers (2016–2016)